- Profile
- Personal Information
- Publications
Experts in Biomedical Sciences
Jon P Mochel Zhao Zhidong Mark Ehrensberger Limin Chen Jason R. Wiles Anirban Dutta Fakhri Al-Bagdadi Hermann Bragulla Jun Xia Levent Dirikolu Yun Wu Albert H. Titus Debanjan Sarkar Joseph Francis Hitesh Anantray Vyas Charles Lee Martha Littlefield Ciprian N. Ionita J. Michael Mathis Lei L. Ying View MoreMadiha Derouazi
Founder and CEO
Biotechnology Engineering
Amal Therapeutics
Switzerland
Madiha Derouazi has been working on vector engineering and therapeutic cancer vaccines for over 10 years. She has a strong background in applied molecular and cellular biotechnology, with research interests at the interface of fundamental and translational research, the so called bench-to-bedside. After several years working on recombinant protein production (upstream), she started developing different antigen delivery vectors. In the Laboratory of Tumor Immunology of the University of Geneva, she designed and characterized the CPP-based multi-epitopic cancer vaccine that is currently being progressed by Amal Therapeutics. Madiha Derouazi holds a PhD in Biotechnology from the Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland and a Master in Biotechnology Engineering from the University of Technology of Berlin, Germany.
Biotechnology Engineering